文献速递关节外科

单剂量围手术期抗生素不增加单髁膝关节置换术后手术部位感染风险

Single-Dose Perioperative Antibiotics Do Not Increase the Risk of Surgical Site Infection in Unicompartmental Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2019-02-27

研究回顾2007至2017年单外科医生完成的296例单髁膝关节置换术,其中40例门诊手术接受单剂量静脉抗生素,256例住院手术接受24小时静脉抗生素。全队列手术部位感染率为0.7%,住院组0.8%,门诊组0%,两组比较P=1.00。结论认为单剂量围手术期抗生素对单髁膝关节置换术是安全的。

要点

  • 全队列296例单髁膝关节置换术中手术部位感染2例(0.7%)。
  • 住院组256例中感染2例(0.8%),门诊组40例中感染0例(0%),P=1.00。
  • 单剂量围手术期抗生素用于单髁膝关节置换术是安全的。

核心结论

  • 单剂量和24小时静脉抗生素方案下,单髁膝关节置换术后手术部位感染风险均较低(0.8%或以下)。
  • 给予单剂量围手术期抗生素对单髁膝关节置换术是安全的,应可减轻对门诊手术的潜在担忧。

研究设计与样本

  • 评估2007至2017年由学术机构单一外科医生完成的所有单髁膝关节置换术病例。
  • 队列共296例单髁膝关节置换术:40例门诊手术接受单剂量抗生素,256例住院手术接受24小时抗生素。
  • 无患者接受辅助口服抗生素;平均年龄64岁,50%为女性,平均体重指数32 kg/m2,平均随访4.1年(范围1.0-10.4)。
  • 通过前瞻性全关节登记和人工病历审查评估围手术期抗生素方案及术后1年内发生的手术部位感染。

主要发现

  • 全队列296例中手术部位感染2例(0.7%)。
  • 住院单髁膝关节置换术256例中感染2例(0.8%),门诊单髁膝关节置换术40例中感染0例(0%)(P = 1.00)。
  • 1例感染为术后6周发生的深部感染,需二期翻修并转为全膝关节置换术。
  • 另1例为浅表感染,接受2周口服抗生素治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Unicompartmental knee arthroplasty (UKA) is commonly performed as an outpatient procedure. To facilitate this process, a single-dose intravenous (IV) perioperative antibiotic administration is required compared to 24-hour IV antibiotic dosing schedules that are typical of most inpatient arthroplasty procedures. There is a paucity of literature to guide surgeons on the safety of single-dose perioperative antibiotic administration for arthroplasty procedures, particularly those that will be performed in the outpatient setting. The purpose of this study is to evaluate a large series of UKA performed with single-dose vs 24-hour IV antibiotic coverage to determine the impact on risk for surgical site infection (SSI). METHODS: All UKA cases were evaluated from 2007 to 2017 performed by a single surgeon at an academic institution. There were 296 UKAs in the cohort: 40 were outpatient procedures receiving single-dose antibiotics and 256 were inpatient procedures receiving 24-hour antibiotics. No patients were prescribed adjuvant oral antibiotics. Mean age was 64 years, 50% were female, mean body mass index was 32 kg/m2, and mean follow-up was 4.1 years (range 1.0-10.4). Perioperative antibiotic regimen was evaluated and SSI, defined as occurring within 1 year of surgery, was abstracted through a prospective total joint registry and manual chart review. RESULTS: SSI occurred in 2 of 296 cases (0.7%) in the entire cohort, 2 of 256 inpatient UKAs (0.8%), and 0 of 40 outpatient UKAs (0%) (P = 1.00). One SSI was a deep infection occurring 6 weeks postoperatively that required 2-stage exchange and conversion to total knee arthroplasty. The other was a superficial infection treated with 2 weeks of oral antibiotics. CONCLUSION: This study demonstrates a low SSI risk (0.8% or less) following UKA with both single-dose and 24-hour IV antibiotics. Administering single-dose perioperative antibiotics is safe for UKA, which should alleviate that potential concern for outpatient surgery. LEVEL OF EVIDENCE: Level III, Therapeutic.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Wyles CC, Vargas-Hernandez JS, Carlson SW, et al. Single-Dose Perioperative Antibiotics Do Not Increase the Risk of Surgical Site Infection in Unicompartmental Knee Arthroplasty. J Arthroplasty. 2019. PMID: 30910245. doi:10.1016/j.arth.2019.02.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。